Last reviewed · How we verify
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
The purpose of this study is to explore the possible cognitive effects of darifenacin modified release and long-acting oxybutynin.
Details
| Lead sponsor | Novartis |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 150 |
| Start date | 2005-02 |
| Completion | 2005-05 |
Conditions
- Healthy Volunteers
Interventions
- Darifenacin
- Oxybutynin
- Placebo
Primary outcomes
- Cognitive effect: measure of accuracy of delayed recall name-phase association test at week 3.
Countries
United States